Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
---|
05/06/2004 | EP1326836B1 Process for making 3-amino-2-chloro-4-methylpyridine |
05/06/2004 | EP1036072B1 Thrombin receptor antagonists |
05/06/2004 | CA2503462A1 Selected cgrp antagonists, processes for preparing them and their use aspharmaceutical compositions |
05/06/2004 | CA2503455A1 Selected cgrp antagonists, method for production and use thereof as medicament |
05/06/2004 | CA2502488A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
05/06/2004 | CA2500974A1 Nuclear hormone receptor compounds, products and methods employing same |
05/05/2004 | CN1494542A 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
05/05/2004 | CN1494422A Use of GABAA inverse agonists in combination with nicotine receptor partial agonists, estrogen, selective estrogen modulators, or vitamin E for treatment of cognitive disorders |
05/05/2004 | CN1493291A Dicyclic compound capable of inhibiting epidermis growth factor acceptor rotatory tyrosine kinase |
05/05/2004 | CN1148370C Technology for preparing oxymatrine from sophora alopecuroide |
05/05/2004 | CN1148369C 1,8-naphthyridine derivatives |
05/05/2004 | CN1148361C Oxyiminoalkanoic acid derivatives |
05/04/2004 | US6730789 Radiation resistance, weatherproof, washfastness, colorfastness; hair dyes |
05/04/2004 | US6730788 Process for 1,10-phenanthroline ligands |
05/04/2004 | US6730682 Herpes virus |
05/04/2004 | US6730675 Such as 7-chloro-4-hydroxy-2-(2,5-dimethyl(3-furanyl)) methyl-1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-dione which binds nmda receptors (n-methyl-aspartic acid receptors); neuropathy |
05/04/2004 | CA2119756C Process for preparing benzo[b]naphtyridines |
04/29/2004 | WO2004035582A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
04/29/2004 | WO2004035581A1 Spiroheterocyclic derivative compounds and drugs comprising the compounds as the active ingredient |
04/29/2004 | WO2004035580A1 Reactivation of wild type p53 in human tumour cells by a low molecular weight compound |
04/29/2004 | WO2004035579A1 Imidazopyridine derivative, process for producing the same, and use |
04/29/2004 | WO2004035578A1 Substituted c-imidazo[1,2-a]pyridin-3-yl-methylamines |
04/29/2004 | WO2004035577A2 Pre-organized tricyclic integrase inhibitor compounds |
04/29/2004 | WO2004035576A2 Pre-organized tricyclic integrase inhibitor compounds |
04/29/2004 | WO2004035573A1 Method for preparing risperidone |
04/29/2004 | WO2004035569A2 Novel compounds with antibacterial activity |
04/29/2004 | WO2004035564A1 Pyridine derivatives useful as herbicides |
04/29/2004 | WO2004035563A1 3-heterocyclylpyridine derivatives useful as herbicides |
04/29/2004 | WO2004035550A1 Novel bicyclic inhibitors of hormone sensitive lipase |
04/29/2004 | WO2004035549A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
04/29/2004 | WO2004035543A1 Tetrahydroquinoline derivatives as crth2 antagonists |
04/29/2004 | WO2004035536A2 Azo compounds for type i phototherapy |
04/29/2004 | WO2004035522A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
04/29/2004 | WO2004034983A2 Preparation of triazospiro compounds |
04/29/2004 | WO2004034972A2 Compounds, compositions, and methods |
04/29/2004 | WO2004016086A3 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents |
04/29/2004 | WO2004014906A3 Nitro and amino substituted dibenzonaphthyridines as topoisomerase agents |
04/29/2004 | WO2004014389A8 3,4-dihydroquinolin-2-one, 5,6-fused oxazin-3-one, and 5,6-fused thiazin-3-one derivatives as matrix metalloproteinase inhibitors |
04/29/2004 | WO2004013139A3 Process for preparing 7-azaindoles |
04/29/2004 | WO2004006354A3 Polymeric charge transport compositions and electronic devices made with such compositions |
04/29/2004 | WO2003093242A3 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade |
04/29/2004 | WO2003074524A3 Mappicine analogs, intermediates in the synthesis of mappicine analogs and methods of synthesis of mappicine analogs |
04/29/2004 | WO2003028459A8 Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides |
04/29/2004 | WO2002085909A8 9-deazaguanine derivatives as inhibitors of gsk-3 |
04/29/2004 | WO2002078626A3 Therapeutic combinations for cardiovascular and inflammatory indications |
04/29/2004 | US20040082790 Piperidine amides as modulators of chemokine receptor activity |
04/29/2004 | US20040082788 Naphthalimide synthesis including amonafide synthesis and pharmaceutical preparations thereof |
04/29/2004 | US20040082787 Chemical compounds |
04/29/2004 | US20040082784 Anxiolytic agents; antidepressants; Alzheimer, Huntington, Parkinson disease |
04/29/2004 | US20040082781 Bicyclic nitrogenous fused-ring compound |
04/29/2004 | US20040082779 Melanocortin-4 receptor binding compounds and methods of use thereof |
04/29/2004 | US20040082778 Amination process |
04/29/2004 | US20040082635 Fused cyclic compounds and medicinal use thereof |
04/29/2004 | US20040082631 Pyrazole compositions useful as inhibitors of ERK |
04/29/2004 | US20040082625 Osteoporosis, bone disorders |
04/29/2004 | US20040082619 Pyridone derivatives having affinity for cannabinoid 2-type receptor |
04/29/2004 | US20040082609 PGD2 receptor antagonists for the treatment of inflammatory diseases |
04/29/2004 | US20040082605 Use |
04/29/2004 | US20040082604 Antiarthritic agents; osteoporosis; immunosuppressants; antiinflammatory agents; autoimmunology diseases |
04/29/2004 | US20040082603 2,3-Dihydro-isoindol-1-one derivatives |
04/29/2004 | US20040082596 Novel carbamate-substituted pyrazolopyridine derivatives |
04/29/2004 | US20040082592 Metabotropic glutamate receptor antagonists |
04/29/2004 | US20040082585 Anticoagulants; controlling thrombosis; cardiovascular disorders |
04/29/2004 | US20040082584 Antiinflammatory agents; antihistamines; skin disorders; antiarthritic agents; antidiabetic agents; autoimmune disease |
04/29/2004 | US20040082583 Chemical compounds |
04/29/2004 | US20040082573 Anxiolytic agents with reduced sedative and ataxic effects |
04/29/2004 | US20040082563 Thrombosis therapy; antitumor agents; anticoagulants; Factor x inhibitors; anticholesterol agents; cardiovascular disorders; antiinflammatory agents |
04/29/2004 | US20040082562 Novel inhibitors of IMPDH enzyme |
04/29/2004 | US20040082555 Use of gaba, inverse agonists in combination with nicotine receptor partial agonist, estrogen, selective estrogen modulators, or vitamin E for the treatment of cognitive disorders |
04/29/2004 | CA2502515A1 Pyrrolo (3,4-c) carbazole and pyrido (2,3-b) pyrrolo (3,4-e) indole derivatives, preparation method and pharmaceutical compositions containing same |
04/29/2004 | CA2502211A1 Azo compounds for type i phototherapy |
04/29/2004 | CA2501881A1 Pre-organized tricyclic integrase inhibitor compounds |
04/29/2004 | CA2501798A1 Preparation of triazospiro compounds |
04/29/2004 | CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
04/29/2004 | CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists |
04/29/2004 | CA2496633A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein |
04/28/2004 | EP1413553A1 Synthesis of itq-17 in the absence of fluoride ions |
04/28/2004 | EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists |
04/28/2004 | EP1412360A1 COMBINATION THERAPY OF AN SODm AND A CORTICOSTEROID FOR PREVENTION AND/OR TREATMENT OF INFLAMMATORY DISEASE |
04/28/2004 | EP1412354A1 DERIVATIVES OF TRIAZOLYL-IMIDAZOPYRIDINE AND OF THE TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A 2a? RECEPTOR AND THEIR USE AS MEDICAMENTS |
04/28/2004 | EP1412353A1 Imidazopyridinones as p38 map kinase inhibitors |
04/28/2004 | EP1412352A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands |
04/28/2004 | EP1412325A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
04/28/2004 | EP1412078A1 Processes for the production of amino-protected derivatives of 4-aminomethylene-pyrrolidin-3-one and/or 4-aminomethylene-pyrrolidin-3-alkoxyimino derivatives and/or gemifloxacin or a salt thereof |
04/28/2004 | EP1411949A2 8/17 heterocyclic compounds and uses thereof as d-alanyl-d-alanine ligase inhibitors |
04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
04/28/2004 | EP1411939A2 Gaba a-receptor-modulators having nmda-antagonistic activity |
04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
04/28/2004 | EP1289986B1 1,4-diazabicyclo 3.2.2]nonane-phenylisoxazole derivatives, preparation and therapeutic use thereof |
04/28/2004 | EP1261608B1 Diketopiperazine derivatives to inhibit thrombin |
04/28/2004 | EP0971922B1 Tetrahydropyrido compounds |
04/28/2004 | CN1492869A Tricyclic androgen receptor modulator compounds and method |
04/28/2004 | CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists |
04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
04/28/2004 | CN1491944A 5-amino-8-methoxy quinolone carboxylic acid derivatives and its preparation |
04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
04/28/2004 | CN1147489C New bicyclo aminopyrazineone compound, its production process and medical composition containing them |
04/28/2004 | CN1147487C Racemization of R,S-dioxo-benzyl pyrrolopiperidine |